PL2305275T3 - Ciekła kompozycja zawierająca koordynacyjny związek cisplatyny - Google Patents
Ciekła kompozycja zawierająca koordynacyjny związek cisplatynyInfo
- Publication number
- PL2305275T3 PL2305275T3 PL09769989T PL09769989T PL2305275T3 PL 2305275 T3 PL2305275 T3 PL 2305275T3 PL 09769989 T PL09769989 T PL 09769989T PL 09769989 T PL09769989 T PL 09769989T PL 2305275 T3 PL2305275 T3 PL 2305275T3
- Authority
- PL
- Poland
- Prior art keywords
- cisplatin
- liquid composition
- coordinating compound
- coordinating
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/40—Polyamides containing oxygen in the form of ether groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0233—Polyamines derived from (poly)oxazolines, (poly)oxazines or having pendant acyl groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0091—Complexes with metal-heteroatom-bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyamides (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008164814 | 2008-06-24 | ||
| PCT/JP2009/060102 WO2009157279A1 (ja) | 2008-06-24 | 2009-05-27 | シスプラチン配位化合物の液体組成物 |
| EP09769989.6A EP2305275B1 (en) | 2008-06-24 | 2009-05-27 | Liquid composition comprising cisplatin-coordinating compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2305275T3 true PL2305275T3 (pl) | 2013-12-31 |
Family
ID=41444348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09769989T PL2305275T3 (pl) | 2008-06-24 | 2009-05-27 | Ciekła kompozycja zawierająca koordynacyjny związek cisplatyny |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8895076B2 (pl) |
| EP (1) | EP2305275B1 (pl) |
| JP (1) | JP5458255B2 (pl) |
| KR (1) | KR101650907B1 (pl) |
| CN (1) | CN102076345B (pl) |
| AU (1) | AU2009263529B2 (pl) |
| CA (1) | CA2728502C (pl) |
| DK (1) | DK2305275T3 (pl) |
| ES (1) | ES2425772T3 (pl) |
| HK (1) | HK1154801A1 (pl) |
| PL (1) | PL2305275T3 (pl) |
| TW (1) | TWI428145B (pl) |
| WO (1) | WO2009157279A1 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011105792A (ja) * | 2009-11-12 | 2011-06-02 | Japan Science & Technology Agency | ブロックコポリマー、ブロックコポリマー−金属錯体複合体、及びそれを用いた中空構造体キャリア |
| TWI568453B (zh) * | 2011-11-22 | 2017-02-01 | 原創生醫股份有限公司 | 具有螯合型複合微胞之藥物載體及其應用 |
| CN102604082B (zh) * | 2012-02-15 | 2013-12-11 | 中国科学院长春应用化学研究所 | 顺铂配合物及其制备方法 |
| CN103272244A (zh) * | 2013-01-21 | 2013-09-04 | 长春理工大学 | 一种药物键合物、制法及其在治疗肿瘤的应用 |
| AU2015369185B2 (en) | 2014-12-26 | 2020-10-22 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical preparation of camptothecin-containing polymer derivative |
| CA2990369A1 (en) | 2015-06-24 | 2016-12-29 | Nippon Kayaku Kabushiki Kaisha | Novel platinum (iv) complex |
| KR20180039628A (ko) * | 2015-09-03 | 2018-04-18 | 니폰 가야꾸 가부시끼가이샤 | 캄프토테신류 고분자 유도체를 함유하는 의약 조성물 |
| JP6725520B2 (ja) | 2015-09-14 | 2020-07-22 | 日本化薬株式会社 | ６配位白金錯体の高分子結合体 |
| EP3395857B1 (en) | 2015-12-22 | 2021-05-26 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of sulfoxide derivative-coordinated platinum(ii) complex |
| JPWO2018038240A1 (ja) * | 2016-08-26 | 2019-06-24 | 公益財団法人川崎市産業振興財団 | 金属とブロック共重合体との錯体を含むミセルを安定化させる方法および安定化されたミセル、並びにミセルからの金属の放出制御法 |
| WO2019217328A1 (en) | 2018-05-07 | 2019-11-14 | California Institute Of Technology | Gel and polymer based flow meters |
| CN109908084B (zh) * | 2019-04-11 | 2021-06-25 | 临沂大学 | 一种铂交联喜树碱前药胶束纳米药物及其制备方法和应用 |
| US11668613B2 (en) * | 2019-05-06 | 2023-06-06 | California Institute Of Technology | ABA type block co-polymers for temperature sensing and flow meters |
| CN112121176B (zh) * | 2019-06-24 | 2022-07-01 | 山东华铂凯盛生物科技有限公司 | 一种顺铂微粒组成、制备方法及应用 |
| US11912807B2 (en) | 2020-03-25 | 2024-02-27 | Samsung Electronics Co., Ltd. | Composite for sensing heat or infrared light and device including same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9604895A (pt) | 1995-04-14 | 1999-11-30 | Kazunori Kataoka | Polioxietileno tendo um açúcar em uma extremidade e um grupo funcional diferente na outra extremidade, e um processo para a produção do mesmo |
| NZ305471A (en) | 1995-04-19 | 2000-02-28 | Kazunori Kataoka | Use of heterotelechelic block copolymers as carriers for medicaments |
| BR9610053A (pt) | 1995-08-10 | 1999-07-06 | Katoaka Kazunori | Polímetro de blocos tendo grupos funcionais sobre ambas extremidades |
| DE60121016T2 (de) | 2000-09-26 | 2006-12-21 | Toudai Tlo, Ltd. | Polymere mizelle mit darin eingeschlossenem cisplatin und ihre verwendung |
| US7094810B2 (en) * | 2001-06-08 | 2006-08-22 | Labopharm, Inc. | pH-sensitive block copolymers for pharmaceutical compositions |
| JP2003012505A (ja) * | 2001-07-06 | 2003-01-15 | Nano Career Kk | 薬物含有高分子ミセルの凍結乾燥 |
| WO2006057429A1 (ja) * | 2004-11-24 | 2006-06-01 | Nanocarrier Co., Ltd. | ブロックコポリマーのモーフォロジ－の変化方法 |
| WO2007066781A1 (ja) * | 2005-12-05 | 2007-06-14 | Nanocarrier Co., Ltd. | フッ素系有機溶媒を用いた薬物封入ポリマーミセルを含有する医薬組成物の製造方法 |
-
2009
- 2009-05-27 JP JP2010517837A patent/JP5458255B2/ja not_active Expired - Fee Related
- 2009-05-27 ES ES09769989T patent/ES2425772T3/es active Active
- 2009-05-27 DK DK09769989.6T patent/DK2305275T3/da active
- 2009-05-27 US US13/001,006 patent/US8895076B2/en active Active
- 2009-05-27 EP EP09769989.6A patent/EP2305275B1/en active Active
- 2009-05-27 PL PL09769989T patent/PL2305275T3/pl unknown
- 2009-05-27 KR KR1020107028751A patent/KR101650907B1/ko active IP Right Grant
- 2009-05-27 WO PCT/JP2009/060102 patent/WO2009157279A1/ja active Application Filing
- 2009-05-27 CN CN2009801238118A patent/CN102076345B/zh not_active Expired - Fee Related
- 2009-05-27 CA CA2728502A patent/CA2728502C/en active Active
- 2009-05-27 AU AU2009263529A patent/AU2009263529B2/en not_active Ceased
- 2009-06-03 TW TW098118350A patent/TWI428145B/zh not_active IP Right Cessation
-
2011
- 2011-08-30 HK HK11109137.2A patent/HK1154801A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20110110881A1 (en) | 2011-05-12 |
| CA2728502C (en) | 2017-01-03 |
| AU2009263529B2 (en) | 2013-09-26 |
| JPWO2009157279A1 (ja) | 2011-12-08 |
| ES2425772T3 (es) | 2013-10-17 |
| KR20110038629A (ko) | 2011-04-14 |
| TWI428145B (zh) | 2014-03-01 |
| HK1154801A1 (en) | 2012-05-04 |
| WO2009157279A1 (ja) | 2009-12-30 |
| DK2305275T3 (da) | 2013-10-07 |
| CN102076345A (zh) | 2011-05-25 |
| JP5458255B2 (ja) | 2014-04-02 |
| US8895076B2 (en) | 2014-11-25 |
| EP2305275A1 (en) | 2011-04-06 |
| EP2305275A4 (en) | 2012-07-18 |
| KR101650907B1 (ko) | 2016-08-24 |
| EP2305275B1 (en) | 2013-07-10 |
| TW201006497A (en) | 2010-02-16 |
| CN102076345B (zh) | 2013-05-08 |
| CA2728502A1 (en) | 2009-12-30 |
| AU2009263529A1 (en) | 2009-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1154801A1 (en) | Liquid composition comprising cisplatin-coordinating compound | |
| ZA201005268B (en) | Composition | |
| GB0815022D0 (en) | Composition | |
| GB0819633D0 (en) | Composition | |
| GB0822246D0 (en) | Composition | |
| GB0818473D0 (en) | Composition | |
| GB0801119D0 (en) | Composition | |
| GB0810554D0 (en) | Herbicde composition | |
| GB0809808D0 (en) | Composition | |
| GB0811743D0 (en) | Composition | |
| GB0801401D0 (en) | Composition | |
| EP2357204A4 (en) | COMPOSITION | |
| EP2234480A4 (en) | LIQUID CONSERVATIVE COMPOSITIONS | |
| GB0810359D0 (en) | Composition | |
| HK1147698A1 (en) | Composition for external application | |
| GB0817656D0 (en) | Composition | |
| GB0806948D0 (en) | Composition | |
| GB0818269D0 (en) | Composition | |
| GB0813589D0 (en) | Composition | |
| GB0809983D0 (en) | Composition | |
| GB0903681D0 (en) | Composition | |
| GB0823344D0 (en) | Composition | |
| GB0821754D0 (en) | Composition | |
| GB0818231D0 (en) | Composition | |
| GB0818336D0 (en) | Composition |